In a study of the expression of FKN and its receptor in gastric adenocarcinoma analyzed with immunohistochemistry and western blot in hepatocellular carcinoma samples, the authors showed better prognosis and longer survival when both FKN and its receptor were expressed [71]. This evidence concerns the gene CX3CL1 and hepatocellular carcinoma.